Old Web
English
Sign In
Acemap
>
authorDetail
>
Lynn W. Scherer
Lynn W. Scherer
FMC Corporation
Sitagliptin
Clinical trial
Internal medicine
Glycemic
Medicine
4
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
897-P: Demographic and Glycemic Parameters in Global Populations of Younger vs. Older Youth with T2D Randomized in Clinical Trials of Sitagliptin
2021
Diabetes
Ron S. Newfield
Asma Deeb
Muhammad Yazid Jalaludin
Raymundo García
Yulia Samoilova
Carmen A. Rosario
Naim Shehadeh
Chandan Saha
Yilong Zhang
Zhi Jin Xu
Lynn W. Scherer
Samuel S. Engel
Keith D. Kaufman
Philip Zeitler
R. Ravi Shankar
Show All
Source
Cite
Save
Citations (0)
2335-PUB: Clinical Trial of the Use of Sitagliptin in Pediatric Patients with T2D: Baseline Characteristics
2019
Diabetes
Muhammad Yazid Jalaludin
Raymundo García
Ron S. Newfield
Carmen A. Rosario
Yulia Samoilova
Naim Shehadeh
Yilong Zhang
Lynn W. Scherer
Chandan Saha
Samuel S. Engel
Philip Zeitler
Keith D. Kaufman
R. Ravi Shankar
Show All
Source
Cite
Save
Citations (0)
Synthesis and structure-activity relationships of 1-aryl-4-substituted-1,4-dihydro-5H-tetrazol-5-ones, a novel class of pre- and post-emergence herbicides
1990
Pesticide Science
George Theodoridis
Frederick W. Hotzman
Lynn W. Scherer
Bruce A. Smith
John M. Tymonko
Michael J. Wyle
Show All
Source
Cite
Save
Citations (14)
1